Skip to main content

Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN

Medically reviewed by Carmen Pope, BPharm. Last updated on June 24, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, June 24, 2024 -- For high-risk patients with hypertension, vigorous physical activity (VPA) may preserve cognitive function, according to a study published online June 6 in Alzheimer's & Dementia.

Richard Kazibwe, M.D., from the Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues categorized the baseline self-reported frequency of VPA into low and high (less than one and at least one session/week, respectively) and examined the association between VPA categories with incident mild cognitive impairment (MCI) and probable dementia events among individuals with high-risk hypertension.

The researchers found that low event rates per 1,000 person-years were seen for MCI (13.9 versus 19.7), probable dementia (6.3 versus 9.0), and MCI/probable dementia (18.5 versus 25.8) for participants in the high versus the low VPA category. High versus low VPA was associated with lower risk of MCI, probable dementia, and MCI/probable dementia in the multivariable Cox regression model (hazard ratios [95 percent confidence intervals], 0.81 [0.68 to 0.97], 0.80 [0.63 to 1.03], and 0.82 [0.70 to 0.96], respectively).

"We know that physical exercise offers many benefits, including lowering blood pressure, improving heart health, and potentially delaying cognitive decline," Kazibwe said in a statement. "However, the amount and the intensity of exercise needed to preserve cognition is unknown."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted June 2024

Read this next

Echocardiogram Can ID Women With Preeclampsia at Risk for Future HTN

WEDNESDAY, June 26, 2024 -- Echocardiography during pregnancy or early postpartum can assist in identifying women with preeclampsia at greater risk of future hypertension...

Angiotensin Receptor Blocker Use Linked to Lower Incidence of Epilepsy

FRIDAY, June 21, 2024 -- For patients with hypertension, angiotensin receptor blockers (ARBs) are associated with a reduced incidence of epilepsy compared with other...

Cognitive Impairment Delayed With Genetic Variant

THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant (APOE3Ch), according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.